Perioperative anticoagulation for patients with mechanical heart valves: A survey of current practice

Journal of Thrombosis and Thrombolysis

Volumn 18, Issue 3, 2004, Pages 199-203

  Garcia, David A ^a   Ageno, Walter ^b   Libby, Edward N ^a   Bibb, John ^a   Douketis, James ^c   Crowther, Mark A ^c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulation; Heart valves; Perioperative; Surgery

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA PROSTHESIS; ARTICLE; CASE REPORT; CONSENSUS; DRUG CHOICE; DRUG MEGADOSE; FEMALE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; LOW DRUG DOSE; MALE; MEDICAL EXPERT; MITRAL VALVE PROSTHESIS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 17544382391     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-0346-5     Document Type: Article

References (20)

1. Martinell J, Jimenez A, Rabago G, Artiz V, Fraile J, Farre J. Mechanical cardiac valve thrombosis. Is thrombectomy justified? Circulation 1991;84(5 Suppl):III70-III75.
2. Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of prosthetic valve anticoagulation. [Review] [169 refs]. Mayo Clin Proc 1998;73(7):665-680.
3. Longstreth WT, Jr., Bernick C, Fitzpatrick A, et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001;56(3):368-375.
4. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):204S-233S.
5. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107(12):1692-1711.
6. Douketis J, Crowther M, Cherian SS, Kearon C. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999;116:1240-1246.
7. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999;130(10):800-809. 1:CAS:528:DyaK1MXjslKmtro%3D
8. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003.
9. Carrel TP, Klingenmann W, Mohacsi PJ, Berdat P, Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: An institutional review. J Heart Valve Dis 1999;8(4):392-398.
10. Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J 1978;96(2):163-165.
11. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110(12):1658-1663.
12. Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003;89(5):527-530.
13. Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001;35(6):669-674.
14. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84(4):478-480, A10.
15. Bonow RO, Carabello B, de Leon AC, Jr., et al. Guidelines for the management of patients with valvular heart disease: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98(18):1949-1984.
16. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease - Native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):457S-82S.
17. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50(10):1129-1136.
18. Holden J, Holden K. Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. J Clin Pharm Ther 2000;25(1):49-54.
19. Taylor FC, Gray A, Cohen H, Gaminara L, Ramsay M, Miller D. Costs and effectiveness of a nurse specialist anticoagulant service. J Clin Pathol 1997;50(10):823-828.
20. Willey ML, Chagan L, Sisca TS, et al. A pharmacist-managed anticoagulation clinic: Six-year assessment of patient outcomes. Am J Health Syst Pharm 2003;60(10):1033-1037.